Variables associated with HbA1c and weight reductions when adding liraglutide to multiple daily insulin injections in persons with type 2 diabetes (MDI Liraglutide trial 3)

Dahlqvist, S; Ahlen, E; Filipsson, K; Gustafsson, T; Hirsch, IB; Tuomilehto, J; Imberg, H; Ahren, B; Attvall, S; Lind, M

Dahlqvist, S (reprint author), NU Hosp Grp, Dept Med, Uddevalla, Sweden.

BMJ OPEN DIABETES RESEARCH & CARE, 2018; 6 (1):

Abstract

Objective To evaluate variables associated with hemoglobin A1c (HbA1c) and weight reduction when adding liraglutide to persons with type 2 diabetes tr......

Full Text Link